文献速递神经肿瘤

垂体腺瘤经蝶手术切除患者代谢综合征及其组分的改善

Improvement of metabolic syndrome and its components in patients who underwent transsphenoidal resection for pituitary adenoma.
PubMed 文献 · Acta Neurochir (Wien) · 2024-02-16

该研究评估垂体腺瘤患者经蝶手术前后代谢状态变化,共纳入214例患者,按腺瘤类型和手术成功程度分层。术后代谢综合征患病率从51.52%降至28.99%(P<0.001),高血糖改善最明显(56%降至40.51%,P=0.03)。全切除组改善最佳,代谢综合征患病率从83%降至16%(P<0.001),但高α脂蛋白血症除外。不同腺瘤类型间代谢综合征改善无差异。

要点

  • 经蝶手术治疗垂体腺瘤与代谢综合征改善相关,患病率从51.52%降至28.99%(P<0.001)。
  • 全切除组代谢综合征患病率从83%降至16%(P<0.001),各组分除高α脂蛋白血症外均显著改善。
  • 不同腺瘤类型间代谢综合征改善无差异。

核心结论

  • 垂体腺瘤患者的手术治疗与代谢综合征改善相关。

研究设计与样本

  • 评估接受经蝶手术治疗的垂体腺瘤患者,记录术前和术后代谢参数,分析全样本变化,并按腺瘤类型(无功能、生长激素细胞、催乳素细胞、促肾上腺皮质激素细胞)和手术成功程度(全切除、近全切除、部分切除、次全切除)分层。共纳入214例患者。

主要发现

  • 采用AACE标准的代谢综合征患病率从术前51.52%降至术后28.99%(P<0.001)。
  • 高血糖是最受益的组分,从术前56%降至术后40.51%(P=0.03)。
  • 全切除组改善最佳,代谢综合征患病率从83%降至16%(P<0.001),肥胖从96%降至67%(P<0.001),动脉高血压从59%降至24%(P<0.001),高血糖从74%降至23%(P<0.001),高甘油三酯血症从81%降至54%(P<0.001),但高α脂蛋白血症除外。
  • 根据代谢综合征患病率,不同垂体腺瘤类型之间的改善无差异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pituitary adenomas (PA) are neoplasms of pituitary adenohypophyseal cell lineage, which are the third most common cause of brain tumors among adults. Due to hormone secretion, PAs are closely related to metabolic syndrome (MetS). However, the relationship between these two entities has been scarcely studied to date. PURPOSE: This paper aims to evaluate changes in the metabolic status of patients with PA before and after surgical treatment and to look for differences in metabolic outcomes among patients according to the adenoma type and the surgery success rate. METHODS: We assessed patients with PA who went through transsphenoidal surgery for its treatment, documenting metabolic parameters before and after surgery, analyzed whole sample changes, and then stratified them according to adenoma type (nonfunctioning, somatotroph, lactotroph, and corticotroph), and surgery success (total resection, near-total resection, partial resection, subtotal resection). RESULTS: A total of 214 patients were enrolled for this study. The prevalence of MetS with AACE criteria went from 51.52% before surgery to 28.99% after surgery (P < 0.001). Hyperglycemia (HG) was the most beneficial component; it went from 56% pre-surgery to 40.51% post-surgery (P = 0.03). The total resection group had the best improvement, with a significant decrease of prevalence in MetS from 83 to 16% (P < 0.001), and every component, except hypoalphalipoproteinemia (HA): obesity went from 96 to 67% (P < 0.001), arterial hypertension (AH) 59 to 24% (P < 0.001), HG 74 to 23% (P < 0.001), and hypertriglyceridemia (HTG) from 81 to 54% (P < 0.001). According to MetS prevalence, there was no difference in the improvement according to PA type. CONCLUSION: Surgical treatment in patients with PA is associated with MetS improvement.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Cortés-Contreras AP, Salazar-Pigeon A, González-Almazán JA, et al. Improvement of metabolic syndrome and its components in patients who underwent transsphenoidal resection for pituitary adenoma. Acta Neurochir (Wien). 2024. PMID: 38363400. doi:10.1007/s00701-024-05938-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。